You are here
HIV positive mothers likely to stop treatment after delivery
15 September, 2014
Mothers living with HIV in South Africa often discontinue HIV care after their child is born and has tested negative for HIV, as they perceive their own health as unimportant.
The war on drugs has failed: Global Commission on Drug Policy launches new report
12 September, 2014
The Global Commission on Drug Policy met this week in New York for the launch their new report, Taking Control: pathways to drug policies that work. The report calls on world leaders and policymakers to re-think and reform global drug policy, moving away from the ‘war on drugs’ stance, which they argue has failed, to a stance focused on human rights and access to healthcare.
Visceral leishmaniasis-HIV co-infection an emerging global health issue
10 September, 2014
Visceral leishmaniasis-HIV (VL/HIV) co-infection is an emerging global health issue, prominent in Africa, and on the rise in South America and India. Visceral leishmaniasis (VL) is a disease that develops from the leishmaniasis parasite, which is transmitted via the bite of a sand fly. VL is the biggest global parasite killer after malaria, and is a major concern for people living with HIV (PLHIV) as a potentially life threatening co-infection.
Drugs shortage in free antiretroviral treatment programs in India is trouble for the poor
9 September, 2014
Shortages of antiretroviral treatment in India cause that many people living with HIV are unable to access the needed drugs through government run distribution centres.
Targeting high-risk groups with HIV prevention services cost-effective for public health
5 September, 2014
Large-scale HIV prevention programmes targeted at high-risk populations can be enormously cost-effective for public health, according to new research conducted on the Avahan HIV prevention programme in India. The researchers found that in a concentrated epidemic, targeting services at key affected populations, including sex workers and men who have sex with men, will be effective both in averting new infections, and prove to be value for money over time.
Rise in HIV prevalence among South Sudanese refugees in Uganda
2 September, 2014
There has been an estimated 15 percent increase in new HIV infections among South Sudanese refugees in a Ugandan refugee camp. Since the conflict in South Sudan re-erupted, 1.5 million people have been displaced, with over 421,000 fleeing to neighbouring countries such as Uganda. In one Ugandan refugee camp, Kiryandogo, the population is increasing every day with an expected 35,000 refugees by the end of 2014.
Corporate social responsibility to combat HIV in the workforce
22 August, 2014
Organisations operating in countries with a high HIV prevalence are increasingly making efforts to tackle the epidemic and develop strategies to reduce workers risk of HIV. Ill health and loss of life are major negative cost of the epidemic; however it also has the effect of crippling economies, as a significant proportion of the work force is affected. Industries such as oil and gas have realised that addressing HIV makes business sense, as well as ensuring the well-being of thousands of people.
HIV research and prevention programs at risk with decline in investments
19 August, 2014
The HIV Vaccines and Microbicides Resource Tracking Working Group reports that the total amount spent on HIV prevention research dropped in 2013. Key reasons are a reduction in investments by the United States and European government donors and changes in the international development landscape.